Home » Corporate events » 2013 » October 4 – 7, 2013

October 4 – 7, 2013

Alethia Biotherapeutics to present at the Annual ASBMR Meeting at the Baltimore Convention Center, Baltimore, USA.  Drs. Julie Laurin and Gilles Tremblay will present data on a new generation of bone antiresoprtive:

Effects of AB-25E9, a Monoclonal Antibody Targeting Siglec-15, on Biomarkers of Bone Remodeling in Estrogen-Deficient Cynomolgus Monkeys . Poster presentation #SA0420, October   5

An Antibody Targeting Siglec-15 Decreases Bone Loss in OVX Rats by Reducing Osteoclast Acitivity and Increasing Bone Formation. Poster presentation #SU0260, October 6